{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:42:58Z","timestamp":1769110978206,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00347-021-01467-5","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:02:51Z","timestamp":1628146971000},"page":"1107-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Update intraven\u00f6se Lysetherapie","Update on intravenous lysis treatment"],"prefix":"10.1007","volume":"118","author":[{"given":"Maximilian","family":"Schultheiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Olof","family":"Hattenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"1467_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jon.12112","volume":"25","author":"M Altmann","year":"2015","unstructured":"Altmann\u00a0M, Ertl\u00a0M, Helbig\u00a0H et\u00a0al (2015) Low endogenous recanalization in embolic central retinal artery occlusion\u2014the retrobulbar \u201cspot sign\u201d. J\u00a0Neuroimaging 25:251\u2013256","journal-title":"J Neuroimaging"},{"key":"1467_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/WNO.0b013e31814b1f66","volume":"27","author":"V Biousse","year":"2007","unstructured":"Biousse\u00a0V, Calvetti\u00a0O, Bruce\u00a0BB et\u00a0al (2007) Thrombolysis for central retinal artery occlusion. J\u00a0Neuroophthalmol 27:215\u2013230","journal-title":"J Neuroophthalmol"},{"key":"1467_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","volume":"394","author":"BCV Campbell","year":"2019","unstructured":"Campbell\u00a0BCV, Ma\u00a0H, Ringleb\u00a0PA et al (2019) Extending thrombolysis to 4.5\u20139\u202fh and wake-up stroke using perfusion imaging: a\u00a0systematic review and meta-analysis of individual patient data. Lancet 394:139\u2013147","journal-title":"Lancet"},{"key":"1467_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5527292","author":"M Casagrande","year":"2021","unstructured":"Casagrande\u00a0M, Kromer\u00a0R, Wenzel\u00a0DA et al (2021) Determination of Ischemia onset based on automatically generated Spectralis SD-OCT values in acute central retinal artery occlusion. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/5527292","journal-title":"J Ophthalmol"},{"key":"1467_CR5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","volume":"42","author":"CS Chen","year":"2011","unstructured":"Chen\u00a0CS, Lee\u00a0AW, Campbell\u00a0B et al (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a\u00a0randomized, controlled trial. Stroke 42:2229\u20132234","journal-title":"Stroke"},{"key":"1467_CR6","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/IAE.0000000000001017","volume":"36","author":"H Chen","year":"2016","unstructured":"Chen\u00a0H, Xia\u00a0H, Qiu\u00a0Z et\u00a0al (2016) Correlation of optical intensity on optical coherence tomography and visual outcome in central retinal artery occlusion. Retina 36:1964\u20131970","journal-title":"Retina"},{"key":"1467_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson\u00a0J, Lees\u00a0KR, Lyden\u00a0P et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a\u00a0meta-analysis of individual patient data from randomised trials. Lancet 384:1929\u20131935","journal-title":"Lancet"},{"key":"1467_CR8","doi-asserted-by":"publisher","first-page":"E263","DOI":"10.1055\/s-0032-1312925","volume":"33","author":"M Ertl","year":"2012","unstructured":"Ertl\u00a0M, Altmann\u00a0M, Torka\u00a0E et al (2012) The retrobulbar \u201cspot sign\u201d as a\u00a0discriminator between vasculitic and thrombo-embolic affections of the retinal blood supply. Ultraschall Med 33:E263\u2013E267","journal-title":"Ultraschall Med"},{"key":"1467_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41433-019-0576-y","volume":"34","author":"M Fallico","year":"2020","unstructured":"Fallico\u00a0M, Lotery\u00a0AJ, Longo\u00a0A et al (2020) Risk of acute stroke in patients with retinal artery occlusion: a\u00a0systematic review and meta-analysis. Eye (Lond) 34:683\u2013689","journal-title":"Eye (Lond)"},{"key":"1467_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","volume":"146","author":"LO Hattenbach","year":"2008","unstructured":"Hattenbach\u00a0LO, Kuhli-Hattenbach\u00a0C, Scharrer\u00a0I et al (2008) Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146:700\u2013706","journal-title":"Am J Ophthalmol"},{"key":"1467_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.preteyeres.2011.05.001","volume":"30","author":"SS Hayreh","year":"2011","unstructured":"Hayreh\u00a0SS (2011) Acute retinal arterial occlusive disorders. Prog Retin Eye Res 30:359\u2013394","journal-title":"Prog Retin Eye Res"},{"key":"1467_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/bjo.64.11.818","volume":"64","author":"SS Hayreh","year":"1980","unstructured":"Hayreh\u00a0SS, Weingeist\u00a0TA (1980) Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br J Ophthalmol 64:818\u2013825","journal-title":"Br J Ophthalmol"},{"key":"1467_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","volume":"140","author":"SS Hayreh","year":"2005","unstructured":"Hayreh\u00a0SS, Zimmerman\u00a0MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140:376\u2013391","journal-title":"Am J Ophthalmol"},{"key":"1467_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","volume":"78","author":"SS Hayreh","year":"2004","unstructured":"Hayreh\u00a0SS, Zimmerman\u00a0MB, Kimura\u00a0A et\u00a0al (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78:723\u2013736","journal-title":"Exp Eye Res"},{"key":"1467_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/archopht.120.9.1234","volume":"120","author":"JC Kattah","year":"2002","unstructured":"Kattah\u00a0JC, Wang\u00a0DZ, Reddy\u00a0C (2002) Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 120:1234\u20131236","journal-title":"Arch Ophthalmol"},{"key":"1467_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000437274","volume":"40","author":"F Lauda","year":"2015","unstructured":"Lauda\u00a0F, Neugebauer\u00a0H, Reiber\u00a0L et\u00a0al (2015) Acute silent brain infarction in monocular visual loss of Ischemic origin. Cerebrovasc Dis 40:151\u2013156","journal-title":"Cerebrovasc Dis"},{"key":"1467_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajo.2018.08.027","volume":"196","author":"P Lavin","year":"2018","unstructured":"Lavin\u00a0P, Patrylo\u00a0M, Hollar\u00a0M et\u00a0al (2018) Stroke risk and risk factors in patients with central retinal artery occlusion. Am J Ophthalmol 196:96\u2013100","journal-title":"Am J Ophthalmol"},{"key":"1467_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajo.2014.01.033","volume":"157","author":"J Lee","year":"2014","unstructured":"Lee\u00a0J, Kim\u00a0SW, Lee\u00a0SC et al (2014) Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study. Am J Ophthalmol 157:1231\u20131238","journal-title":"Am J Ophthalmol"},{"key":"1467_CR19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","volume":"51","author":"MB Grory","year":"2020","unstructured":"Grory\u00a0MB, Nackenoff\u00a0A, Poli\u00a0S et al (2020) Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke 51:2018\u20132025","journal-title":"Stroke"},{"key":"1467_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.06.001","volume":"49","author":"D Mcleod","year":"2015","unstructured":"Mcleod\u00a0D, Beatty\u00a0S (2015) Evidence for an enduring ischaemic penumbra following central retinal artery occlusion, with implications for fibrinolytic therapy. Prog Retin Eye Res 49:82\u2013119","journal-title":"Prog Retin Eye Res"},{"key":"1467_CR21","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/STROKEAHA.115.009839","volume":"46","author":"M Nedelmann","year":"2015","unstructured":"Nedelmann\u00a0M, Graef\u00a0M, Weinand\u00a0F et\u00a0al (2015) Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion. Stroke 46:2322\u20132324","journal-title":"Stroke"},{"key":"1467_CR22","doi-asserted-by":"publisher","first-page":"P120","DOI":"10.1016\/j.ophtha.2016.09.024","volume":"124","author":"TW Olsen","year":"2017","unstructured":"Olsen\u00a0TW, Pulido\u00a0JS, Folk\u00a0JC et\u00a0al (2017) Retinal and ophthalmic artery occlusions preferred practice pattern(R). Ophthalmology 124:P120\u2013P143","journal-title":"Ophthalmology"},{"key":"1467_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/1747493016687578","volume":"12","author":"C Preterre","year":"2017","unstructured":"Preterre\u00a0C, Godeneche\u00a0G, Vandamme\u00a0X et\u00a0al (2017) Management of acute central retinal artery occlusion: intravenous thrombolysis is feasible and safe. Int J Stroke 12:720\u2013723","journal-title":"Int J Stroke"},{"key":"1467_CR24","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","volume":"38","author":"JH Rha","year":"2007","unstructured":"Rha\u00a0JH, Saver\u00a0JL (2007) The impact of recanalization on ischemic stroke outcome: a\u00a0meta-analysis. Stroke 38:967\u2013973","journal-title":"Stroke"},{"key":"1467_CR25","doi-asserted-by":"publisher","unstructured":"Schnieder M, Fischer-Wedi CV, Bemme S et al (2021) The Retrobulbar spot sign and prominent middle limiting membrane as prognostic markers in non-arteritic retinal artery occlusion. J\u00a0Clin Med 10. https:\/\/doi.org\/10.3390\/jcm10020338","DOI":"10.3390\/jcm10020338"},{"key":"1467_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag\u00a0M, Youn\u00a0T, Schindler\u00a0J et al (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72:1148\u20131154","journal-title":"JAMA Neurol"},{"key":"1467_CR27","doi-asserted-by":"publisher","first-page":"e0198114","DOI":"10.1371\/journal.pone.0198114","volume":"13","author":"M Schultheiss","year":"2018","unstructured":"Schultheiss\u00a0M, Hartig\u00a0F, Spitzer\u00a0MS et\u00a0al (2018) Intravenous thrombolysis in acute central retinal artery occlusion\u2014a prospective interventional case series. PLoS ONE 13:e198114","journal-title":"PLoS ONE"},{"key":"1467_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","volume":"117","author":"M Schumacher","year":"2010","unstructured":"Schumacher\u00a0M, Schmidt\u00a0D, Jurklies\u00a0B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a\u00a0multicenter randomized trial. Ophthalmology 117:1367\u20131375 e1","journal-title":"Ophthalmology"},{"key":"1467_CR29","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.12659\/MSM.892259","volume":"20","author":"L Shi","year":"2014","unstructured":"Shi\u00a0L, Zhang\u00a0M, Liu\u00a0H et al (2014) Safety and outcome of thrombolysis in mild stroke: a\u00a0meta-analysis. Med Sci Monit 20:2117\u20132124","journal-title":"Med Sci Monit"},{"key":"1467_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","volume":"379","author":"G Thomalla","year":"2018","unstructured":"Thomalla\u00a0G, Simonsen\u00a0CZ, Boutitie\u00a0F et al (2018) MRI-guided thrombolysis for stroke with unknown time of onset. N\u00a0Engl J Med 379:611\u2013622","journal-title":"N Engl J Med"},{"key":"1467_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213.pub3","author":"JM Wardlaw","year":"2014","unstructured":"Wardlaw\u00a0JM, Murray\u00a0V, Berge\u00a0E et\u00a0al (2014) Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000213.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1467_CR32","doi-asserted-by":"publisher","unstructured":"Wenzel DA, Kromer R, Poli S et al (2020) Optical coherence tomography-based determination of ischaemia onset\u2014the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14563","DOI":"10.1111\/aos.14563"},{"key":"1467_CR33","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.04.008","volume":"23","author":"LLL Yeo","year":"2014","unstructured":"Yeo\u00a0LLL, Ho\u00a0R, Paliwal\u00a0P et al (2014) Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis. J\u00a0Stroke Cerebrovasc Dis 23:2156\u20132162","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01467-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01467-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01467-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T15:05:23Z","timestamp":1636038323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01467-5"}},"subtitle":["Die REVISION-Studie","The REVISION trial"],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1467"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01467-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"7 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Schultheiss, M.S.\u00a0Spitzer und S.\u00a0Poli sind die Initiatoren der REVISION-Studie (ClinicalTrials.gov Identifier: NCT04965038). Zudem unterst\u00fctzt Boehringer-Ingelheim Pharma GmbH & Co. KG die Studie durch die Bereitstellung der Studienmedikation (Verum und Placebo). L.-O.\u00a0Hattenbach gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}